Gene: OTUD1
Official Full Name: OTU deubiquitinase 1provided by HGNC
Gene Summary: Deubiquitinating enzymes (DUBs; see MIM 603478) are proteases that specifically cleave ubiquitin (MIM 191339) linkages, negating the action of ubiquitin ligases. DUBA7 belongs to a DUB subfamily characterized by an ovarian tumor (OTU) domain.[supplied by OMIM, May 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28062 | OTUD1 Knockout cell line (HeLa) | Human | OTUD1 | 1:3~1:6 | Negative | Online Inquiry |
KO28063 | OTUD1 Knockout cell line (HCT 116) | Human | OTUD1 | 1:2~1:4 | Negative | Online Inquiry |
KO28064 | OTUD1 Knockout cell line (HEK293) | Human | OTUD1 | 1:3~1:6 | Negative | Online Inquiry |
KO28065 | OTUD1 Knockout cell line (A549) | Human | OTUD1 | 1:3~1:4 | Negative | Online Inquiry |
OTUD1 Gene Knockout Cell Lines are genetically engineered cell lines designed to ablate the expression of the OTUD1 gene, a crucial component of the ubiquitin proteolytic system. This gene plays a vital role in deubiquitination, regulating protein stability and signaling pathways essential for cellular homeostasis. By knocking out OTUD1, researchers can investigate the specific cellular processes that are affected when this regulatory node is compromised, facilitating the study of various biological pathways associated with cancer, immune response, and cellular stress.
The functioning of the OTUD1 Gene Knockout Cell Lines operates through gene editing technologies, such as CRISPR-Cas9 or similar methodologies, which introduce targeted mutations to disrupt the OTUD1 coding sequence. This leads to a loss of function that enables researchers to explore the gene's role in various signaling cascades, protein interactions, and disease modeling. Such insights are invaluable in elucidating mechanisms of action in drug responses and therapeutic targets.
Scientifically, these cell lines have significant applications in both research and clinical settings, particularly in studying the dynamics of cellular signaling and protein degradation in diseases, including cancer. By utilizing OTUD1 knockouts, researchers can derive essential insights into tumorigenesis or therapeutic resistance, providing critical information for drug development and precision medicine initiatives.
One distinct advantage of OTUD1 Gene Knockout Cell Lines over other gene manipulation tools is their specificity and reproducibility, which allow for more meaningful data collection on how the absence of OTUD1 affects cellular behavior. Unlike traditional overexpression models, knockout cell lines provide a clearer understanding of loss-of-function scenarios that mimic clinical pathologies more accurately.
For researchers and clinicians aiming to explore the complexities of protein regulation and its consequences in pathological contexts, OTUD1 Gene Knockout Cell Lines are an indispensable tool. The ability to manipulate this crucial gene expands the toolkit for biological research, potentially leading to breakthroughs in understanding tumor biology and therapeutic approaches.
Our company specializes in providing high-quality gene knockout cell lines, driven by a commitment to advancing research capabilities through innovative biotechnological solutions. With expertly crafted products and a strong foundation in molecular biology, we equip researchers with the necessary tools to drive their scientific inquiries forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.